Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trialJingxin Li, Fengcai Zhu, Wei Chen et al.|Nature Medicine|2022Cited by 163
Heterologous prime-boost immunization with CoronaVac and ConvideciaJingxin Li, Fengcai Zhu, Lunbiao Cui et al.|medRxiv|2021Cited by 33
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialPengfei Jin, Jingxin Li, Yawen Zhu et al.|Expert Review of Vaccines|2024Cited by 0